Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial

Hyung Duk Kim; Ji-Yeun Chang; Byung Ha Chung; Chan-Duck Kim; Sang-Ho Lee; Yeong Hoon Kim; Chul Woo Yang

doi:10.12659/AOT.927984

22 January 2021 : Original article

Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial

Hyung Duk Kim^1BEF, Ji-Yeun Chang^1CDE, Byung Ha Chung^1AB, Chan-Duck Kim^2B, Sang-Ho Lee^3B, Yeong Hoon Kim^4B, Chul Woo Yang^1ADG*

DOI: 10.12659/AOT.927984

Ann Transplant 2021; 26:e927984

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 4 Change of microalbuminuria. The figure shows the difference in MAU from the baseline to 12 months in the EVL (black column) and standard group (white column). Vertical error bars indicate the respective standard deviations. MAU – microalbuminuria; EVL – everolimus * P<0.05 compared to baseline.

Back to the Article

Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial

Your Privacy